{
    "title": "AbbVie may see less pain from Humira sales decline as rival lags",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12340901/AbbVie-pain-Humira-sales-decline-rival-lags.html",
    "date": "2023-07-26",
    "keywords": [
        "humira",
        "drug",
        "abbvie",
        "share",
        "price",
        "year",
        "leo",
        "july",
        "inc",
        "street",
        "market",
        "company",
        "erosion",
        "launch",
        "month",
        "rate",
        "quarter",
        "copycat",
        "blockbuster",
        "arthritis",
        "traction",
        "thursday",
        "prescription",
        "drugmaker",
        "drop",
        "majority",
        "hit",
        "half",
        "biosimilar",
        "amgen",
        "amjevita",
        "exane",
        "analyst",
        "navann",
        "ty",
        "product",
        "caremark",
        "cignas",
        "express",
        "script",
        "bank",
        "context",
        "generic",
        "medication",
        "discount",
        "tag",
        "coverage",
        "pharmacy",
        "benefit",
        "demand",
        "week",
        "immunology",
        "rinvoq",
        "skyrizi",
        "term",
        "revenue",
        "profit",
        "wall",
        "sentiment",
        "target",
        "upside",
        "closing",
        "reporting",
        "bengaluru",
        "editing",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}